PMGC HOLDINGS INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets
PMGC HOLDINGS INC. (ELAB) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets of $4.92 million as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Notes
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets · last filed 2024-03-29
- 2023-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets $4.92M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets |
|---|---|
| 2023-12-31 | $4.92M 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |